Edoardo Francini

10PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 12, 2026
Circulating Tumor DNA as Emerging Predictive and Prognostic Biomarker in Prostate Cancer.

|Jan 25, 2025
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies.

Giandomenico Roviello, Irene De Gennaro, Ismaela Vascotto

|Feb 10, 2024
Cell-Free DNA: Unveiling the Future of Cancer Diagnostics and Monitoring.

Edoardo Francini, Pier Vitale Nuzzo, Giuseppe Nicolò Fanelli

|Feb 04, 2023
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer.

Pier Vitale Nuzzo, Filippo Pederzoli, Calogero Saieva

|Dec 11, 2022
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study.

Valerio Gristina, Nadia Barraco, Maria La Mantia

|Sep 23, 2022
Circulating Cell-Free DNA in Renal Cell Carcinoma: The New Era of Precision Medicine.

Edoardo Francini, Giuseppe Nicolò Fanelli, Filippo Pederzoli

Pageof 2

Frequent Collaborators

2 joint publications

Giuseppe Nicolò Fanelli

2 joint publications

Pier Vitale Nuzzo

1 joint publications

Lauren C Harshman

1 joint publications

Bradley McGregor